The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader FunctionalityYadira Lobaina, Lisset Hermida, Gerardo Guillén et al.|Viruses|2024Cited by 11
A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader ResponseYadira Lobaina, Lisset Hermida, Rong Chen et al.|Vaccines|2024Cited by 6
The Nucleocapsid Protein Of SARS-CoV-2, Combined With ODN-39M, Is A Potential Component For An Intranasal Bivalent Pancorona VaccineYadira Lobaina, Lisset Hermida, Rong Chen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3
Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2Yadira Lobaina, Lisset Hermida, Rong Chen et al.|Archives of Virology|2023Cited by 1
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidatesYadira Lobaina, Lisset Hermida, Alexis Musacchio et al.|Virology Journal|2024Cited by 1